Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXI3BK
|
||||
Drug Name |
4-(8-Chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-piperazine-1-carboxylic acid (1-oxy-pyridin-3-yl)-amide
|
||||
Synonyms |
CHEMBL171597
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C24H24ClN5O2
|
||||
Canonical SMILES |
[O-][n+]1cccc(NC(=O)N2CCN(CC2)C3c4ccc(Cl)cc4CCc5cccnc35)c1
|
||||
InChI |
InChI=1S/C24H24ClN5O2/c25-19-7-8-21-18(15-19)6-5-17-3-1-9-26-22(17)23(21)28-11-13-29(14-12-28)24(31)27-20-4-2-10-30(32)16-20/h1-4,7-10,15-16,23H,5-6,11-14H2,(H,27,31)
|
||||
InChIKey |
OQWJKOITLPKNGK-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.